NRx Pharmaceuticals will hold a conference call on October 30, 2026, to discuss a regulatory milestone for its preservative-free ketamine program and outline next steps for its commercial launch. The company recently received an Abbreviated New Drug Approval (ANDA) for this ketamine formulation and is pursuing New Drug Approval for an intravenous ketamine treatment targeting depression and suicidality. This milestone is significant as it advances NRx's efforts in developing treatments for central nervous system disorders, including depression and PTSD. Investors can expect details in a press release before the market opens on the day of the call.
NRx Pharmaceuticals' upcoming conference call on October 30, 2026, provides context for health sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 30, 2026 03:11 WIB: out of 150 priced health-sector US stocks, 106 rose and 44 fell. Notable movers include CTXR at USD 0.60 with a 10.64% gain, WGS at USD 71.25 up 10.14%, and BAX at USD 23.43 down 7.97%.
iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...
NEO Battery Materials Ltd. reported Q2 2026 revenue of CAD 203,566 with a gross loss reflecting early-stage production scale-up. The company secured significant contracts including its first direct order from the Republic of Korea Army, a large found...
Polaris Inc. announced a quarterly cash dividend of $0.68 per share, payable on December 15, 2026, to shareholders recorded by December 1, 2026. This dividend reflects Polaris's ongoing commitment to returning value to its shareholders. As a global l...
Amazon's third-quarter earnings fell short of analyst expectations for both total revenue and earnings per share, with net sales at $201.9 billion versus the expected $202.2 billion, and EPS at $1.89 against $1.97 expected. However, its cloud divisio...
Solana (SOL) fell 4.94% to $96.74 within four hours on October 29, with a 5.67% decline over 24 hours. This drop triggered $23.05 million in long position liquidations across major exchanges, far exceeding short liquidations. The significant sell-off...
